JPS5390267A - Piperidine derivative - Google Patents

Piperidine derivative

Info

Publication number
JPS5390267A
JPS5390267A JP13773777A JP13773777A JPS5390267A JP S5390267 A JPS5390267 A JP S5390267A JP 13773777 A JP13773777 A JP 13773777A JP 13773777 A JP13773777 A JP 13773777A JP S5390267 A JPS5390267 A JP S5390267A
Authority
JP
Japan
Prior art keywords
piperidine derivative
piperidine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13773777A
Other languages
English (en)
Other versions
JPS6127388B2 (ja
Inventor
Bega Noberora Arumando
Boitsukusu Igureshiasu Hose
Purieto Soto Hose
Morakesu Mauri Yashinto
Jiyofurei Uiriamu Sup Roberuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anphar SA
Original Assignee
Anphar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anphar SA filed Critical Anphar SA
Publication of JPS5390267A publication Critical patent/JPS5390267A/ja
Publication of JPS6127388B2 publication Critical patent/JPS6127388B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP13773777A 1976-11-16 1977-11-16 Piperidine derivative Granted JPS5390267A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB47739/76A GB1574418A (en) 1976-11-16 1976-11-16 Piperidine derivatives

Publications (2)

Publication Number Publication Date
JPS5390267A true JPS5390267A (en) 1978-08-08
JPS6127388B2 JPS6127388B2 (ja) 1986-06-25

Family

ID=10446086

Family Applications (2)

Application Number Title Priority Date Filing Date
JP13773677A Granted JPS5387365A (en) 1976-11-16 1977-11-16 Piperidine derivative
JP13773777A Granted JPS5390267A (en) 1976-11-16 1977-11-16 Piperidine derivative

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP13773677A Granted JPS5387365A (en) 1976-11-16 1977-11-16 Piperidine derivative

Country Status (13)

Country Link
US (1) US5026858A (ja)
JP (2) JPS5387365A (ja)
AT (2) AT360014B (ja)
AU (2) AU517830B2 (ja)
BE (2) BE860737A (ja)
CA (2) CA1095046A (ja)
DE (2) DE2751139A1 (ja)
ES (4) ES464145A1 (ja)
FR (2) FR2370732A1 (ja)
GB (1) GB1574418A (ja)
IE (2) IE45989B1 (ja)
NL (2) NL7712570A (ja)
ZA (2) ZA776587B (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1574418A (en) * 1976-11-16 1980-09-03 Anphar Sa Piperidine derivatives
FR2546169B1 (fr) * 1983-05-20 1986-03-21 Delalande Sa N-oxydes de derives aminocycliques, leur procede de preparation et leur application en therapeutique
US4820715A (en) * 1984-06-28 1989-04-11 Bristol-Myers Company Anti-emetic quinuclidinyl benzamides
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides
US5011992A (en) * 1984-06-28 1991-04-30 Bristol-Myers Squibb Company Pharmacologically active substituted benzamides
GB8519707D0 (en) * 1985-08-06 1985-09-11 Fordonal Sa Chemical compounds
CA2141048C (en) * 1992-08-19 2003-03-18 Harry R. Howard Substituted benzylamino nitrogen containing non-aromatic heterocycles
US5739135A (en) * 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5885983A (en) * 1996-05-10 1999-03-23 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5827875A (en) * 1996-05-10 1998-10-27 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5883109A (en) * 1996-07-24 1999-03-16 Bristol-Myers Squibb Company Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
US6339087B1 (en) 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
DE69938193D1 (de) * 1998-11-20 2008-04-03 Hoffmann La Roche Piperidin ccr-3 rezeptor-hemmer
FR2802206B1 (fr) * 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
TW200800953A (en) * 2002-10-30 2008-01-01 Theravance Inc Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine
WO2005007645A1 (en) * 2003-07-11 2005-01-27 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds
WO2005053663A2 (en) * 2003-11-24 2005-06-16 Eli Lilly And Company Norepinephrine reuptake inhibitors useful for treatment of cognitive failure
DE602006009804D1 (de) * 2005-06-02 2009-11-26 Hoffmann La Roche Piperidin-4-yl-amidderivate und ihre verwendung als antagonisten des sst-rezeptors vom subtyp 5
JP2009264436A (ja) 2008-04-23 2009-11-12 Funai Electric Co Ltd トルクリミッタ装置、トルクリミッタ装置を備えた表示画面旋回装置およびトルクリミッタ装置を含むテレビジョン装置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1019781A (ja) * 1963-03-05
FR1407055A (fr) * 1963-03-05 1965-07-30 Ile De France Nouveau procédé de préparation de benzamides substitués
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR5916M (ja) * 1966-01-21 1968-05-06
US3577440A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-amido-pyrrolidines
GB1345872A (en) * 1970-09-03 1974-02-06 Wyeth John & Brother Ltd Amino-and acylamino-pyridine and hydropyridine derivatives
US3963745A (en) * 1972-04-03 1976-06-15 A. H. Robins Company, Incorporated Method for controlling emesis with N-(1-substituted-3-pyrrolidinyl)benzamides and thiobenzamides
DE2513136C3 (de) * 1974-03-21 1981-04-30 Anphar S.A., Madrid N-(1-Benzylpiperid-4-yl)-benzamide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
US4163789A (en) * 1976-02-17 1979-08-07 Anphar, S.A. Anti-psychotic (cycloalkenylalkylpiperidino) benzamides
GB1513631A (en) * 1976-02-17 1978-06-07 Gallardo Antonio Sa Piperidine derivatives
GB1574418A (en) * 1976-11-16 1980-09-03 Anphar Sa Piperidine derivatives

Also Published As

Publication number Publication date
ATA817077A (de) 1980-05-15
ES464147A1 (es) 1978-09-01
ES464146A1 (es) 1978-09-01
JPS5387365A (en) 1978-08-01
FR2370732B1 (ja) 1980-07-04
FR2370733A1 (fr) 1978-06-09
AU3067377A (en) 1979-05-24
IE45989B1 (en) 1983-01-26
AT360014B (de) 1980-12-10
FR2370733B1 (ja) 1980-07-04
BE860736A (fr) 1978-03-01
ZA776587B (en) 1978-09-27
AU517830B2 (en) 1981-08-27
JPS6126782B2 (ja) 1986-06-21
AU3067277A (en) 1979-05-24
IE46090B1 (en) 1983-02-23
GB1574418A (en) 1980-09-03
CA1095046A (en) 1981-02-03
JPS6127388B2 (ja) 1986-06-25
IE45989L (en) 1978-05-16
ZA776588B (en) 1978-08-30
DE2751139A1 (de) 1978-05-24
US5026858A (en) 1991-06-25
BE860737A (fr) 1978-03-01
DE2751138A1 (de) 1978-05-24
NL7712570A (nl) 1978-05-18
ES464144A1 (es) 1978-09-01
CA1094072A (en) 1981-01-20
IE46090L (en) 1978-05-16
AU517004B2 (en) 1981-07-02
ATA817177A (de) 1980-05-15
AT360013B (de) 1980-12-10
FR2370732A1 (fr) 1978-06-09
ES464145A1 (es) 1978-09-01
NL7712559A (nl) 1978-05-18

Similar Documents

Publication Publication Date Title
JPS5377069A (en) Piperidine derivative
JPS5387364A (en) Piperidine derivative
GB1516780A (en) Piperidine derivatives
JPS5387365A (en) Piperidine derivative
JPS5337696A (en) Hexahydrocantinonee6 derivative
GB1532671A (en) Piperidine derivatives
JPS52133928A (en) Nnphosphonomethylglycine derivative
JPS52113978A (en) Novel piperidine derivative
CY1269A (en) Morphanthridine derivative
JPS5321185A (en) Half synthesizzd oleandmycin derivative
JPS5387367A (en) Piperidine derivative
JPS52122378A (en) Piperidine derivative
GB2007219B (en) 4-phenyl-thieno piperidine derivatives
PH12671A (en) Imidaisoquinoline derivative
PH13715A (en) Napethyl derivative
PH13260A (en) 4-(1-hydroxy-1-nethylethyl)-3-cyclorexen-1-one derivative
JPS52116461A (en) Dibenzothiphene derivative
JPS52133988A (en) Substituted pyrandione derivative
JPS5398973A (en) Isoquinolineacetoamide derivative
JPS5283470A (en) Piperidine derivatives
JPS5285176A (en) Novel piperidine derivatives
JPS539776A (en) 11methyll44*22carboxyy thioxanthenee99ilydene** piperidine
AU493335B2 (en) Piperidine derivatives
JPS52133976A (en) 22phenyllindole derivative
JPS5283499A (en) Indolobenzazepine derivative